Non-Vascular Stents Market Share and Trends

The research scope covers estimations of the market for all types of non-vascular stent products used for treating strictures, palliative care and other conditions resulting in blockage of non-vascular passages within the human body. This encompassed Gastrointestinal stents, tracheobronchial or pulmonary, biliary, prostatic, pancreatic and ureteral stents. This five year forecast provides an accurate perspective since the research includes various macro & micro-economic factors that affect the market indirectly along with the trends within the market such as product approvals and recalls that directly affect the market dynamics.

Global Non-Vascular stents market was valued at US$ 501.3 million in 2014. Presence of the largest companies such as Boston Scientific, Cook Medical, and Merit Medical has prevented other regions to compete with North America. Nonetheless several players have surmounted the approval process of U.S. FDA and now compete in the American market.

Report Sample@ http://www.sa-brc.com/Global-Non-Vascular-Stents-Market-Assessment--Forecast-2015---2019/sample17

Rising incidences in esophageal cancer, colorectal cancer, biliary strictures and prostate cancer have invigorated what has been otherwise a low-key market till date. The cost of non-vascular stents offered by top players in U.S. and Europe has conventionally overshadowed small manufacturers from Asia-Pacific and Middle-East countries such as Israel. However, with the advent of multiple international approvals in the last half a decade several Asia-Pacific players such as Taewoong Medical, Micro Tech (Nanjing) Co Ltd., and Stentech have amassed excellent reviews from the medical fraternity. This also means that leaders such as Boston Scientific and Cook Medical now have other products to reckon with. These giants have however taken the fight to the doorstep of small players with Boston Scientific and Merit Medical Endotek penetrating Asia-Pacific and Latin American markets with strong enterprising collaborations and partnerships.

The market as a whole is lagging behind in terms of product pipeline, although there are several signs to show that there is no lack in innovation. Biodegradable stents for non-vascular applications are very few and are now being seriously considered as a potential opportunity considering the acceptance and response for vascular applications by the endovascular experts. Drug eluting stents for non-vascular applications is another growing area for players to focus.

Click For TOC@ http://www.sa-brc.com/report/Global-Non-Vascular-Stents-Market-Assessment--Forecast-2015---2019/17

That being said, the market continues to grow only at a moderate CAGR of 4.0% and in 2014, the global market for NV stents valued at US$ 501.3 million. The sheer volume of people facing urological problems meant that ureteral stents accounted for the highest share, although price of stents kept the growth lower than stent market for other applications such as biliary and prostatic. In terms of demography, North America and Europe contributed to the greatest revenues in 2014 with total share close to 50% of the global market. Price offerings for stents in these regions and the greater awareness of usage and adoption assure that these regions will continue to lead throughout the forecast period.

About Us
Spearhead Acuity Business Research & Consulting Private Limited (SA-BRC) is a premium Life Science business intelligence and data analytics firm. SA-BRC team offers a wide range of business intelligence services to multiple stakeholders such as Medical Device Manufacturers, Service Providers (Hospitals, Payers, etc.), Suppliers, Group Purchase Organizations, Distributors and all other individuals in the entire value chain of healthcare industry. Our research and consulting capabilities extend across several sub-domains within the sphere of Life Sciences such as Biotechnology, Healthcare IT, Medical Devices, Veterinary Sciences, Wellness Products and Pharmaceuticals.

Contact Us
John Whitmore
10685-B Hazelhurst Drive,
Suite 17411
Houston, Texas 77043,
United States
Phone: +1(832)-426-3701
Email: sales@sa-brc.com
Website: www.sa-brc.com

This release was published on openPR.